Pfizer's COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, according to a large study published Wednesday.
Doses of the anti-viral drug Paxlovid are displayed in New York, on Monday, Aug. 1, 2022. Pfizer's COVID-19 pill may provide little benefit for younger adults, while still reducing the risk of hospitalization and death for higher-risk seniors, according to an Israeli study published Wednesday, Aug 24, 2022.
The study has limitations due to its design, which compiled data from a large Israeli health system rather than enrolling patients in a randomized study with a control group — the gold-standard for medical research. At the time of the FDA decision there were no options for treating COVID-19 at home, and Paxlovid was considered critical to curbing hospitalizations and deaths during the pandemic's second winter surge. The drug's results were also far stronger than a competing pill from Merck.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Post-COVID Symptoms in Kids: Not Always Long COVIDDo kids get long COVID? Look for these unique signs and symptoms. MedTwitter
Read more »
A cross-country analysis of macroeconomic responses to COVID-19 pandemic using Twitter sentimentsThe COVID-19 pandemic has had a devastating impact on the global economy. In this paper, we use the Phillips curve to compare and analyze the macroeconomics of three different countries with distinct income levels, namely, lower-middle (Nigeria), upper-middle (South Africa), and high (Canada) income. We aim to (1) find macroeconomic changes in the three countries during the pandemic compared to pre-pandemic time, (2) compare the countries in terms of response to the COVID-19 economic crisis, and (3) compare their expected economic reaction to the COVID-19 pandemic in the near future. An advantage to our work is that we analyze macroeconomics on a monthly basis to capture the shocks and rapid changes caused by on and off rounds of lockdowns. We use the volume and social sentiments of the Twitter data to approximate the macroeconomic statistics. We apply four different machine learning algorithms to estimate the unemployment rate of South Africa and Nigeria on monthly basis. The results show that at the beginning of the pandemic the unemployment rate increased for all the three countries. However, Canada was able to control and reduce the unemployment rate during the COVID-19 pandemic. Nonetheless, in line with the Phillips curve short-run, the inflation rate of Canada increased to a level that has never occurred in more than fifteen years. Nigeria and South Africa have not been able to control the unemployment rate and did not return to the pre-COVID-19 level. Yet, the inflation rate has increased in both countries. The inflation rate is still comparable to the pre-COVID-19 level in South Africa, but based on the Phillips curve short-run, it will increase further, if the unemployment rate decreases. Unfortunately, Nigeria is experiencing a horrible stagflation and a wild increase in both unemployment and inflation rates. This shows how vulnerable lower-middle-income countries could be to lockdowns and economic restrictions. In the near future, the main concern for al
Read more »
First lady Jill Biden tests positive for COVID-19 in rebound caseThe first lady first tested positive on Aug. 16 and she remained in isolation for five days, undergoing a course of Paxlovid treatment. She tested positive again Wednesday and does not have symptoms.
Read more »
First lady Jill Biden tests positive again for COVID-19 in 'rebound' caseJill Biden first tested positive for the virus on Aug. 15, when she and her husband were vacationing in Kiawah Island, S.C.
Read more »
First lady Jill Biden tests positive for rebound case of COVID-19Jill Biden has been forced to isolate again after testing positive for a rebound case of COVID-19 on Wednesday.
Read more »
Expert talks transmissibility, vaccine efficacy across COVID variants - KCBS Radio: On-DemandToday's segment covers why it's important to study the differences in COVID variants, and what that can tell us about COVID treatments and vaccines. To answer your questions, KCBS Radio news anchors Melissa Culross and Eric Thomas spoke with Dr. Vineet Menachery -- Assistant Professor in the Department of Microbiology and Immunology at the University of Texas Medical Branch in Galveston. If you have a question you would like answered please email us at: askuskcbsradio.com.
Read more »